Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-19 06:44 am Sale | 2021-11-16 | 13D | Trillium Therapeutics Inc. TRIL | Growth Equity Opportunities V LLC | 0 0.000% | -6,586,363 (Position Closed) | Filing History |
| 2021-11-15 4:35 pm Sale | 2021-11-15 | 13G | Trillium Therapeutics Inc. TRIL | RA CAPITAL MANAGEMENT LLC | 0 0.000% | -5,290,481 (Position Closed) | Filing History |
| 2021-08-31 6:43 pm Unchanged | 2021-08-20 | 13D | Trillium Therapeutics Inc. TRIL | Growth Equity Opportunities V LLC | 6,586,363 6.300% | 0 (Unchanged) | Filing History |
| 2021-04-07 4:32 pm Unchanged | 2020-04-01 | 13G | Trillium Therapeutics Inc. TRIL | RA CAPITAL MANAGEMENT LLC | 5,290,481 5.100% | 0 (Unchanged) | Filing History |
| 2021-02-16 5:17 pm Sale | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Boxer Capital LLC | 0 0.000% | -4,425,000 (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | RA CAPITAL MANAGEMENT LLC | 5,290,481 5.300% | 5,290,481 (New Position) | Filing History |
| 2021-02-16 4:11 pm Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Venrock Healthcare Capital Partners III, L.P. | 4,040,000 4.000% | 1,250,000 (+44.80%) | Filing History |
| 2021-02-12 4:30 pm Unchanged | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Vivo Capital IX LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | AVORO CAPITAL ADVISORS LLC | 5,800,000 5.700% | 5,800,000 (New Position) | Filing History |
| 2020-05-11 4:13 pm Sale | 2020-04-30 | 13G | Trillium Therapeutics Inc. TRIL | MORGAN STANLEY MS | 1,243,313 1.500% | -626,691 (-33.51%) | Filing History |